Zimmer Biomet stock: Kevin Thornal plans $529K sale

Kevin R. Thornal filed a Rule 144 notice to potentially sell 5,691 ZBH common shares valued at about $528,978 through Fidelity.

Rhea-AI Filing Summary

ZIMMER BIOMET HOLDINGS, INC. (ZBH) is the issuer of common stock that Kevin R. Thornal plans to sell under Rule 144. The notice covers up to 5,691 shares of common stock, with an aggregate market value of $528,978.45, to be sold through Fidelity Brokerage Services LLC on the NYSE on or before September 11, 2026.

The shares are reported as having been acquired from the issuer on August 1, 2026 upon restricted stock vesting as compensation.

Key Figures

Shares proposed to be sold: 5,691 shares Aggregate market value: $528,978.45 Acquisition date of shares: August 1, 2026 +1 more

4 metrics

Shares proposed to be sold 5,691 shares Common stock covered by the Rule 144 notice for ZIMMER BIOMET HOLDINGS, INC.

Aggregate market value $528,978.45 Total market value for the 5,691 ZIMMER BIOMET common shares in the Rule 144 filing

Acquisition date of shares August 1, 2026 Date the shares were acquired via restricted stock vesting as compensation

Planned sale deadline September 11, 2026 Date associated with the planned sale of the covered shares on the NYSE

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 08/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin R."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for ZBH?

It discloses that Kevin R. Thornal filed a notice of proposed sale under Rule 144 for up to 5,691 shares of ZIMMER BIOMET HOLDINGS, INC. common stock, with an aggregate market value of $528,978.45, to be sold through Fidelity Brokerage Services LLC.

How many ZIMMER BIOMET (ZBH) shares may be sold under this Form 144?

The notice covers a proposed sale of up to 5,691 shares of ZIMMER BIOMET HOLDINGS, INC. common stock. These shares are to be sold through Fidelity Brokerage Services LLC on the NYSE.

What is the aggregate market value of the ZBH shares in this Form 144?

The filing states an aggregate market value of $528,978.45 for the 5,691 shares of ZIMMER BIOMET common stock covered by the Rule 144 notice.

When were the ZBH shares to be sold under this Form 144 acquired?

The shares are reported as acquired on August 1, 2026 through restricted stock vesting from the issuer as compensation.

Who is executing the potential sale of ZBH shares for this Form 144?

The proposed sale would be executed through Fidelity Brokerage Services LLC, acting as broker for the 5,691 shares of ZIMMER BIOMET common stock listed in the notice.

Who signed the Form 144 related to ZIMMER BIOMET (ZBH)?

The Form 144 is signed by /s/ Emily Navaro, as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kevin R. Thornal, on September 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 10:12 AM Accepted by SEC EDGAR 09/11/2026 - 10:11 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783992
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ZIMMER BIOMET HOLDINGS, INC.
SEC File Number	001-16407
Address of Issuer	345 EAST MAIN STREET WARSAW INDIANA 46580
Phone	5742676131
Name of Person for Whose Account the Securities are To Be Sold	Thornal Kevin R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5691	528978.45	190737689	09/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2026	Restricted Stock Vesting	Issuer			5691	08/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Emily Navaro, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin R. Thornal.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)